Lazarus CDS leverages Artificial Intelligence to improve early cancer detection by turning a primary care doctor into a specialist for 5 minutes. For diseases like cervical cancer, this is as simple as a simple prompt that alerts physicians of high-risk patients, enabling them to make better clinical decisions. In skin cancer, we turn any mobile device into an AI-powered dermascope, automatically classifying risk based on a whole host of factors. Best of all, it's fully explainable. No black boxes, just real results.

Lazarus uses patient health data and AI to detect cancer early. The company has clinical decision support systems for skin and cervical cancer, which help improve the diagnostic accuracy of physicians.

500 proprietary risk assessment algorithms focused on early disease risk detection to improve early disease and diagnosis.

Elevate medical practice by earlier disease detection and improved diagnosis via more accurate data collection, better risk and symptom assessment, faster charting, and increased revenue by higher level E&M billing. Now, achieve better outcomes in less time for more money.

Discover SOAP, a patented and clinically validated, Epic, AthenaHealth, etc. EHR-integrated, conversational AI-powered patient and physician-facing interface for more accurate patient data collection and analysis; an unrelenting focus on improving patient outcomes and eliminating administrative burdens. 

Patented and clinically validated AI-powered new "Gold Standard" of more accurate, truthful and comprehensive patient interviews in less time for more money, risk and symptom assessment, differential diagnosis and note creation.

Patented and clinically validated AI-powered new "Gold Standard" of more accurate, truthful and comprehensive patient interviews in less time for more money, risk and symptom assessment, differential diagnosis and note creation. Less time to provide better care for more money.